[New York, NY – January 15, 2025] – Ovarian Cancer Research Alliance (OCRA) proudly announces the extraordinary success of its 2024 year-end fundraising campaign, surpassing its $2 million goal and marking a transformative milestone in its mission to eradicate ovarian and related gynecologic cancers. Fueled by the generosity and unwavering support of donors, this achievement … Continued
A study recently published in Science Advances and supported in part by Ovarian Cancer Research Alliance has advanced scientists’ understanding of how to potentially overcome immune evasion in ovarian cancer. The research team involved current and former Memorial Sloan Kettering Cancer Center researchers, including OCRA grantee Melica Brodeur MD, MSc, now at McGill University, who … Continued
More than 60 gynecologic cancer patients and survivors came together at the end of December for holiday merriment, celebrating of participants’ triumphs, and embracing the new year during a special session of Ovarian Cancer Research Alliance’s online expressive arts series facilitated by our oncology social workers. Ahead of this Express Yourself session, which centered on … Continued
A Year of Progress: Advances in the Fight Against Ovarian and All Gynecologic Cancers This year, your support enabled Ovarian Cancer Research Alliance (OCRA) to make incredible strides in research, advocacy, and patient support for those facing ovarian and all gynecologic cancers. With your help, we expanded our support programs, fostered critical collaborations, and continued … Continued
As we close out 2024, we at OCRA are reflecting on a year of powerful advocacy and immense gratitude. Your passion and commitment to raising awareness, driving policy change, and pushing for progress for the ovarian and gynecologic cancer community have left a mark that will be felt for years to come. Here are some … Continued
OCRA-funded research using artificial intelligence (AI) for ovarian cancer early detection was highlighted in the BBC’s six-part series on how AI is transforming medicine. Dr. Daniel Heller, an OCRA-funded researcher at Memorial Sloan Kettering Cancer Center, shared how his team is using AI and nanotechnology to develop a cutting-edge blood test for early ovarian cancer … Continued
“To improve patient outcomes – and quality of life – we must minimize roadblocks for access to cancer screenings that could change the course of a diagnosis. The time is now. We are urging Congressional action this week to enact this legislation into law.” The Ovarian Cancer Research Alliance today released the following statement regarding … Continued
IQVIA Institute for Human Data Science recently shared key takeaways from its panel discussion on global oncology trends that included OCRA President & CEO Audra Moran, MPN Research Foundation CEO Kapila Viges, and IQVIA Oncology Center of Excellence Vice President Jeff Hodge. The discussion, which was moderated by IQVIA Institute for Human Data Science Executive … Continued
OCRA recently joined the Inter-Organization Cancer Genetics Clinical Evidence Coalition (INTERACT), which is working to ensure genetic testing access for all who may carry inherited mutations that increase the risk of ovarian and other cancers. The coalition, which includes patient advocacy and industry members, endeavors to drive changes in cancer-related genetic testing policies to expand … Continued
OCRA’s Survivors Teaching Students® (STS) program was recently highlighted on St. Louis Public Radio’s St. Louis on the Air in an episode titled “How Ovarian Cancer Survivors are Helping Educate Medical Students.” The discussion featured Drs. Andrea Hagemann and Ian Hagemann alongside OCRA’s STS volunteers Catherine Mikolay and Joan Gummels. Together, they shared how this … Continued
International Forum on Ovarian Cancer Aims to Accelerate Progress Ovarian Cancer Research Alliance (OCRA) President and CEO Audra Moran, along with members of the OCRA team, joined leading scientists and non-profit executives from across the globe this October at the Helene Harris Memorial Trust (HHMT) International Forum on Ovarian Cancer. This prestigious conference, organized by … Continued
Closing out 2024 and Looking Ahead to 2025 As we approach the close of this year’s legislative calendar, the urgency surrounding the federal budget process cannot be overstated. If action is not taken before December 20, the federal government will shut down. At OCRA, we understand that every dollar allocated to cancer research represents hope … Continued
Get email updates about research news, action alerts, and ways to join the fight.
A global, Al-powered ecosystem designed to transform gynecologic cancer research—connecting patients, researchers, and clinicians to accelerate breakthroughs.
Our website uses cookies to ensure you get the best experience. By continuing to use this website, you indicate that you have read and agree to our Terms of Use and Privacy Policy.
